Cargando…

COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis

BACKGROUND: Despite overall improvement in breast cancer patient outcomes from earlier diagnosis and personalised treatment approaches, some patients continue to experience recurrence and incurable metastases. It is therefore imperative to understand the molecular changes that allow transition from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hancock, Janelle L., Kalimutho, Murugan, Straube, Jasmin, Lim, Malcolm, Gresshoff, Irma, Saunus, Jodi M., Lee, Jason S., Lakhani, Sunil R., Simpson, Kaylene J., Bush, Ashley I., Anderson, Robin L., Khanna, Kum Kum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111822/ https://www.ncbi.nlm.nih.gov/pubmed/37072858 http://dx.doi.org/10.1186/s13046-023-02663-8

Ejemplares similares

CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer
por: Makhale, Ashwini, et al.
Publicado: (2021)

Regulation of murine copper homeostasis by members of the COMMD protein family
por: Singla, Amika, et al.
Publicado: (2021)

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2019)

CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
por: Kalimutho, Murugan, et al.
Publicado: (2018)

The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells
por: Anderson, Alison M., et al.
Publicado: (2017)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

BRCA1 A-Complex fine tunes repair functions of BRCA1
por: Harris, Janelle L, et al.
Publicado: (2011)

Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8(+) T-cells infiltration in triple-negative breast cancer
por: Kalimutho, Murugan, et al.
Publicado: (2019)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

Enhanced dependency of KRAS‐mutant colorectal cancer cells on RAD51‐dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae
por: Kalimutho, Murugan, et al.
Publicado: (2017)

CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors
por: Lu, Xue, et al.
Publicado: (2022)

Molecular Aspects of Breast Cancer Metastasis to the Brain
por: Saunus, Jodi M., et al.
Publicado: (2011)

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)

Targeting BRF2 in Cancer Using Repurposed Drugs
por: Rashidieh, Behnam, et al.
Publicado: (2021)

Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation
por: Vonk, Willianne I. M., et al.
Publicado: (2011)

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
por: Saunus, Jodi M., et al.
Publicado: (2022)

Cep55 overexpression promotes genomic instability and tumorigenesis in mice
por: Sinha, Debottam, et al.
Publicado: (2020)

Reduced FXR Target Gene Expression in Copper-Laden Livers of COMMD1-Deficient Dogs
por: Wu, Xiaoyan, et al.
Publicado: (2019)

Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2022)

A Comprehensive Review on Current Advances in Peptide Drug Development and Design
por: Lee, Andy Chi-Lung, et al.
Publicado: (2019)

Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
por: Raninga, Prahlad V., et al.
Publicado: (2020)

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2022)

COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A
por: Phillips-Krawczak, Christine A., et al.
Publicado: (2015)

COMMD1 Exemplifies the Power of Inbred Dogs to Dissect Genetic Causes of Rare Copper-Related Disorders
por: Corbee, Ronald Jan, et al.
Publicado: (2021)

Multi‐omics analysis of the oncogenic value of copper Metabolism‐Related protein COMMD2 in human cancers
por: Tai, Panpan, et al.
Publicado: (2022)

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016)

Notch commandeers COMMD9 for endosomal sorting
por: Short, Ben
Publicado: (2015)

COMMD proteins function and their regulating roles in tumors
por: You, Guangqiang, et al.
Publicado: (2023)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

COMMD1-Deficient Dogs Accumulate Copper in Hepatocytes and Provide a Good Model for Chronic Hepatitis and Fibrosis
por: Favier, Robert P., et al.
Publicado: (2012)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
por: Raghavendra, Ashwini, et al.
Publicado: (2018)

COMMD1-Mediated Ubiquitination Regulates CFTR Trafficking
por: Drévillon, Loïc, et al.
Publicado: (2011)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer
por: Fedoseienko, Alina, et al.
Publicado: (2016)

Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis
por: Rashidieh, Behnam, et al.
Publicado: (2021)

Peptidyl-prolyl isomerization for cytokinetic abscission: Fold and cut
por: van der Horst, Armando, et al.
Publicado: (2012)

Complexities of pharmacogenomic interactions in cancer
por: Khanna, Kum Kum, et al.
Publicado: (2020)

Structural insights into the architecture and membrane interactions of the conserved COMMD proteins
por: Healy, Michael D, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5985su9d9vebj7c416fq0puffp